Summary of FIGS (NYSE:FIGS) FY Conference Call - March 04, 2026 Company Overview - FIGS is a digitally native company specializing in medical scrubs, selling products globally through its website and an emerging retail footprint [14][13] - The company aims to create premium, functional, and comfortable products for healthcare professionals, disrupting a long-standing industry [14][13] Industry Insights - The medical apparel industry is large, mandated, and replenishment-driven, with 140 million healthcare professionals globally [14] - FIGS has 2.9 million active customers, indicating significant growth potential in a market that lacks strong branding [14] Financial Performance - Q4 2025 revenue growth was reported at 33%, attributed to product innovation, effective marketing, and industry normalization [17][21] - Active customer base grew by 9%, with improvements in average order value and orders per customer contributing to revenue growth [44] Product Innovation - FIGS is known for its proprietary FIONx fabric, which is durable and comfortable, and has recently launched FORMx for more intense environments [23][24] - The company has expanded its product line beyond scrubs to include medical-grade compression socks and other accessories, driving broad-based growth [26][27] Marketing Strategy - FIGS has focused on top-of-funnel storytelling and viral marketing campaigns, significantly increasing brand engagement and customer acquisition [18][20] - The company outfitted Team USA's medical team for the 2024 Olympics, enhancing brand visibility [19] Global Expansion - FIGS operates in 59 countries, with a focus on Canada, Mexico, the U.K., and Australia for deeper market penetration [29][30] - International sales grew by 55% in the quarter, with plans to enter 20 additional markets in 2026 [32] Retail Presence - FIGS has transitioned to an omni-channel model with five Community Hubs and plans to open four more, enhancing customer experience and engagement [34][38] - Over 40% of customers in stores are new to the brand, indicating successful customer acquisition strategies [38] B2B Opportunities - The "teams business" is a growing segment, currently less than 10% of total sales, with potential for significant growth as healthcare institutions seek to standardize and brand their teams [39][42] - The concierge medicine market is projected to grow from $15 billion to $30 billion over the next decade, positioning FIGS favorably [43] Financial Outlook - The company anticipates a modest increase in gross margins despite tariff pressures, with a guidance for adjusted EBITDA margin expansion to 12.7%-12.9% in 2026 [52] - FIGS has a strong balance sheet with $300 million in cash and no debt, allowing for continued investment in growth and a share buyback program [54][55] Key Risks and Considerations - Tariff impacts are expected to pressure margins by 400 basis points, but FIGS has strategies in place to mitigate these effects [45][48] - The company is focused on leveraging operational efficiencies and marketing investments to sustain growth and profitability [50][51]

Group 1 - Dr. Motion has partnered with the Peanuts brand to launch a collection of women's everyday compression socks, emphasizing comfort and character [1][3] - The collection features various sock silhouettes, including ankle, quarter, and knee-high, with designs inspired by Peanuts characters like Snoopy and Charlie Brown [1][3] - Dr. Motion sold over 7 million pairs of socks in 2024 and is available in over 6,000 retail stores across the United States, including major retailers like Kohl's and T.J. Maxx [2] Group 2 - The Dr. Motion x Peanuts Collection will be available online and in select stores starting January 2026, marking the beginning of multiple collaborations inspired by Peanuts [3] - Dr. Motion is recognized as a leader in the compression and wellness sock category, having introduced stylish compression socks to the market and continuously expanding its product lines [4] - Peanuts, created by Charles M. Schulz in 1950, has a significant cultural impact and is owned by Peanuts Worldwide, which has partnerships with various companies and initiatives, including a collaboration with NASA [5]

Financial Data and Key Metrics Changes - The company reported over $550 million in sales for the previous year, indicating significant growth despite having only two physical stores [5] - Approximately 70% of revenue is derived from repeat customers, highlighting strong customer loyalty and replenishment dynamics [26] Business Line Data and Key Metrics Changes - The company has transitioned from primarily a scrubs business to a broader range of products, including underscrubs, outerwear, and footwear, with a focus on building a complete wardrobe for healthcare professionals [25][42] - Non-scrub wear currently accounts for roughly 20% of the business, with expectations for continued growth in this segment [42] Market Data and Key Metrics Changes - The company has a brand awareness of about 20% unaided and over 50% aided among healthcare professionals, indicating significant room for growth in customer acquisition [27] - Internationally, the company has less than 1% market share, suggesting substantial opportunities for expansion [29] Company Strategy and Development Direction - The company aims to expand its presence both domestically and internationally, focusing on building out its B2B Teams business and increasing its number of community hubs [6][59] - The strategy includes leveraging partnerships with medical institutions and schools to enhance brand visibility and customer acquisition [61] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the healthcare sector, noting that healthcare jobs are growing three times faster than the average job segment [9] - The company is focused on delivering exceptional products and experiences to healthcare professionals, emphasizing the non-seasonal nature of their business [11] Other Important Information - The company is navigating challenges related to tariffs, with expectations for increased impacts in 2026, but is actively working on mitigation strategies [71][73] - The company has been strategically pulling back on promotions to strengthen brand positioning, with plans for targeted promotions around specific healthcare events [82] Q&A Session Summary Question: What are the growth opportunities from here? - The company sees growth in both scrubs and non-scrubs, with a focus on expanding product offerings and increasing customer loyalty [21][22] Question: How is the Teams business contributing to international growth? - The Teams business is expected to be a significant growth lever internationally, especially as the B2B market is larger outside the U.S. [59][63] Question: What are the expectations for inventory growth? - The company anticipates inventory growth to slightly outpace sales growth, with a focus on product innovation [80] Question: What are the plans for Black Friday and holiday promotions? - The company will continue to participate in Black Friday and Cyber Monday promotions while pulling back on other promotional activities [84]